Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R. Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan, Chythra R. Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind U.K. Rao, Feng Zhou, Hongwu Zheng, Matthew N. Rasband, Yiwen Chen, Fei Lan, Amy B. Heimberger, Benjamin M. Segal, Jian Hu
Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R. Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan, Chythra R. Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind U.K. Rao, Feng Zhou, Hongwu Zheng, Matthew N. Rasband, Yiwen Chen, Fei Lan, Amy B. Heimberger, Benjamin M. Segal, Jian Hu
View: Text | PDF
Research Article Metabolism Neuroscience

Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism

  • Text
  • PDF
Abstract

Lipid-rich myelin forms electrically insulating, axon-wrapping multilayers that are essential for neural function, and mature myelin is traditionally considered metabolically inert. Surprisingly, we discovered that mature myelin lipids undergo rapid turnover, and quaking (Qki) is a major regulator of myelin lipid homeostasis. Oligodendrocyte-specific Qki depletion, without affecting oligodendrocyte survival, resulted in rapid demyelination, within 1 week, and gradually neurological deficits in adult mice. Myelin lipids, especially the monounsaturated fatty acids and very-long-chain fatty acids, were dramatically reduced by Qki depletion, whereas the major myelin proteins remained intact, and the demyelinating phenotypes of Qki-depleted mice were alleviated by a high-fat diet. Mechanistically, Qki serves as a coactivator of the PPARβ-RXRα complex, which controls the transcription of lipid-metabolism genes, particularly those involved in fatty acid desaturation and elongation. Treatment of Qki-depleted mice with PPARβ/RXR agonists significantly alleviated neurological disability and extended survival durations. Furthermore, a subset of lesions from patients with primary progressive multiple sclerosis were characterized by preferential reductions in myelin lipid contents, activities of various lipid metabolism pathways, and expression level of QKI-5 in human oligodendrocytes. Together, our results demonstrate that continuous lipid synthesis is indispensable for mature myelin maintenance and highlight an underappreciated role of lipid metabolism in demyelinating diseases.

Authors

Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R. Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan, Chythra R. Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind U.K. Rao, Feng Zhou, Hongwu Zheng, Matthew N. Rasband, Yiwen Chen, Fei Lan, Amy B. Heimberger, Benjamin M. Segal, Jian Hu

×

Figure 2

Loss of Qki interrupts mature myelin lipid homeostasis.

Options: View larger image (or click on image) Download as PowerPoint
Loss of Qki interrupts mature myelin lipid homeostasis.
(A–C) Representa...
(A–C) Representative images and quantification of PLP (A), MBP (B), and MAG (C) in the corpus callosum of Qk-iCKO mice and controls 1, 2, and 5 weeks post injection (wpi) (n = 4 mice/group). Scale bars: 50 μm. (D and E) Quantification of staining of PLP, MBP, MAG, and FluoroMyelin in the optic nerves (D) and spinal cords (E) of Qk-iCKO mice and controls 5 wpi (n = 4 mice/group). Fl, FluoroMyelin. (F) Immunoblots and quantification showing the expression of PLP, MBP, and myelin oligodendrocyte glycoprotein (MOG) of Qk-iCKO mice and controls 2 and 5 wpi (n = 3 mice/group). (G) Representative images and quantification of staining of FluoroMyelin in the corpus callosum of Qk-iCKO mice and controls 1, 2, and 5 wpi (n = 4 mice/group). Scale bars: 50 μm. (H) Schema depicting the workflow for lipidomic analyses. (I) Quantification of the concentration (μmol/g tissue) of the total lipids measured by mass spectrometry in the spinal cords of Qk-iCKO mice and controls 5 wpi (n = 5 mice/group). (J) Volcano plot (top) illustrating the alterations in the concentrations of each lipid molecule in the samples in I (n = 5 mice/group). The dotted line represents P = 0.05. Pie graph (bottom) illustrating the numbers and percentages of significantly decreased, increased, and unchanged molecules in Qk-iCKO mice relative to controls. (K) Quantification of the concentrations of lipid subclasses in the samples in I (n = 5 mice/group). PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; SM, sphingomyelin; CER, ceramide; HCER, hexosylceramide; LCER, lactosylceramide; DCER, dihydroceramide. Data are mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by 2-way ANOVA with Holm-Sidak multiple-comparisons test (A–C and G) or Student’s t test (D–F, I, and K). NS, not significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts